Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions.

@article{Khandelwal2012OralCP,
  title={Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions.},
  author={Nikhil Khandelwal and Ian Duncan and Tamim Ahmed and Elan Rubinstein and Cheryl L Pegus},
  journal={Journal of the National Comprehensive Cancer Network : JNCCN},
  year={2012},
  volume={10 5},
  pages={
          618-25
        }
}
Adherence, medication wastage, and reduction in hospital admissions were investigated in a retrospective test-control study design for patients enrolled in the oral chemotherapy cycle management program (CMP), a program that offers clinical support, dose monitoring, and early identification of side effects for patients on select oral chemotherapy. Patients who initiated oral chemotherapy with sorafenib, sunitinib, or erlotinib during June 2008 through December 2009 and who were enrolled in the… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 14 REFERENCES

NCCN Task Force Report: Specialty Pharmacy.

  • Journal of the National Comprehensive Cancer Network : JNCCN
  • 2010

Changing reimbursement policies and trends, presentation to association of community cancer

L. Blansett
  • 2009

NCCN clinical practice guidelines in oncology: kidney cancer.

  • Journal of the National Comprehensive Cancer Network : JNCCN
  • 2009

Promises and pitfalls of oral cancer chemotherapy.

  • Clinical advances in hematology & oncology : H&O
  • 2009

NCCN Task Force Report: Oral chemotherapy.

  • Journal of the National Comprehensive Cancer Network : JNCCN
  • 2008